Cerluten research in Canada investigates the neuroprotective and neuronal gene-regulatory properties of this brain tissue peptide bioregulator. Cerluten (Glu-Asp-Arg, EDR) is a tripeptide bioregulator derived from brain tissue that belongs to the Khavinson family of short regulatory peptides. Canadian neuroscience and aging researchers study Cerluten for its effects on neuronal gene expression, protection of neurons from oxidative stress, and potential epigenetic regulatory effects on brain-specific genes through chromatin interaction.
Neuronal Gene Expression Research
Like other Khavinson bioregulators, Cerluten is hypothesized to enter neuronal nuclei and interact directly with chromatin to regulate the expression of brain-specific genes. Canadian neuroscience researchers study how this tripeptide (Glu-Asp-Arg) sequence might preferentially bind to GC-rich promoter regions in neuronal genes, modulating expression of neuroprotective, synaptic, and metabolic genes relevant to brain aging and function.
Brain Aging and Neuroprotection Research
Brain aging involves progressive epigenetic changes that reduce the expression of genes involved in synaptic plasticity, mitochondrial function, and DNA repair in neurons. Canadian neurogerontology researchers study Cerluten to investigate whether brain-derived peptide bioregulators can restore youthful gene expression patterns in aged neuronal models and protect against oxidative stress-induced neuronal damage.
Sourcing Cerluten in Canada
Research-grade Cerluten is available from EhBuddy Peptides in Canada. Lab-tested for purity. For laboratory research use only.
Cerluten adds brain tissue specificity to the Khavinson peptide bioregulator toolkit, offering Canadian neuroscience researchers a brain-targeted epigenetic research tool for studying neuronal aging and neuroprotection.
